About Ujin Pharma IPO

We are engaged in the distribution and supply of a diversified portfolio of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials and nutraceuticals. With over two decades of operational experience in the chemical industry, we have developed sourcing relationships with domestic and international suppliers, enabling us to procure a broad range of chemical products and supply them to traders, distributors and customers operating across multiple end-use industries. Our products are supplied to customers operating in pharmaceutical, agrochemical, specialty chemical, petrochemical, industrial and automotive sectors, as well as paints and coatings, printing inks and packaging applications. Our sourcing capabilities, supported by our distribution network and experience in procurement, logistics coordination and supply chain management, enable us to efficiently procure and supply chemical products across domestic and international markets. We support our customers throughout their procurement process by assisting with purchase planning, consolidating demand, and leveraging our relationships with domestic and international suppliers. We negotiate key commercial terms, including pricing, product specifications, quantities, and delivery schedules, while also managing the end-to-end supply chain, encompassing storage, handling, and logistics support. This integrated approach enables us to provide reliable, timely and cost-effective supply solutions to our customers As per the D&B Report, during the last three Fiscals and the period ended December 31, 2025, our Company supplied an aggregate of approximately 8,52,765.25 MT of chemical products to 3,034 customers. Our operations are supported by a distribution infrastructure comprising various warehouses and storage facilities located across Bhiwandi, Maharashtra and Kandla, Gujarat and a sourcing network of 1,277 suppliers.

Ujin Pharma IPO Subscription Breakdown

Investory CategorySubscription PercentageAmount Raised (₹ Crores)
Qualified Institutional Buyers (QIBs)50%95,75,700 crores
Non-Institutional Investors (NIIs)35%67,02,990 crores
Retail Individual Investors (RIIs)15%28,72,710 crores

Ujin Pharma IPO Financial Highlights

Ujin Pharma’s total income 0.00 by 0.00% and total expenses 0.00 by 0.00%, resulting in an EBITDA 13.09 by -55.81% and a profit after tax (PAT) 0.00 by 0.00% between March 31, 2025 and March 31, 2026.

Amount in Crores
13.09
13.0931 March 2026
29.62
29.6231 March 2025
35.45
35.4531 March 2024

35.45

32

28

25

21

18

14

11

7

4

0.00

EBITDA

Ujin Pharma IPO Strengths & Weaknesses

No Data Found
No Data Found

Ujin Pharma IPO Important Dates & Issue Details

Allotment DateListing DateRefund Date
------
Issue Composition:
Face Value10 per share
Total Issue Size1,91,51,400 shares (aggregating up to To be announced)
Fresh Issue11,86,910 shares (aggregating up to ₹1,18,69,100 crores)
Offer for Sale7,28,230 shares of ₹10 (aggregating up to ₹72,82,300 crores)
Issue TypeBook Building IPO
Post-Issue Shareholding Pattern:
Pre-Issue Shareholding98.5 shares
Post-Issue Shareholding0 shares

Ujin Pharma IPO Lot Size and Investment Details

Minimum Lot Size--
Maximum Lot Size (Retail)--

The lot size of Ujin Pharma ipo has been designed to ensure broad participation while maintaining optimal price discovery.

How to Apply for Ujin Pharma IPO

  1. Log in to your Choice account
  2. Select IPO
  3. Enter the number of lots and your price
  4. Verify UPI ID
  5. Complete the transaction on your UPI app

Ujin Pharma IPO Contact & Registrar Details

Contact Details

Address

Address

610/6th Floor Neelkanth Corporate Park Kirol Road Mumbai

Phone Number

Phone Number

+91 8355847502

Registrar Details

Address

Registrar Name

Kfin Technologies Ltd.

Optivalue Tek Consulting Ltd IPO Lead Manager(s)

Book Running Lead Manager(s)
SMC Capitals Ltd | Marwadi Chandarana Intermediaries Brokers Pvt Ltd

Ujin Pharma IPO FAQs

The minimum lot size is shares with a price band of ₹ to ₹ per share, requiring a minimum investment of ₹.

Check allotment status on the registrar's website using PAN number or application number after the Ujin Pharma IPO allotment date.

The listing date of Ujin Pharma IPO is scheduled for -- on NSE/BSE.

Investment decisions should be based on your risk appetite, financial goals, and a thorough analysis of the company's fundamentals and growth prospects.

Consider factors like company fundamentals, valuation, market conditions, and your investment portfolio before making any investment decision.

You can Ujin Pharma IPO apply online through your broker's trading platform, mobile app, or through the ASBA facility via internet banking.

The Ujin Pharma IPO allotment date and listing date are --and --, respectively.

Yes, you can apply through your bank's internet banking portal. The funds will remain in your account until allotment, and no need for separate IPO funding.